心源性猝死一级预防植入心律转复除颤器前非持续室性心动过速与植入后恰当治疗的关系 : = Relationship between Non-sustained Ventricular Tachycardia before Implantation and Appropriate Therapy in Patients with Implantable Cardioverter Defibrillator for Primary Prevention of Sudden Cardiac Death
目的探讨植入型心律转复除颤器(implantable cardioverter defibrillator,ICD)用于心源性猝死一级预防时,植入前发生非持续性室性心动过速(non-sustained ventricular tachycardia,NSVT)与植入后ICD恰当治疗的关系。方法本研究为单中心回顾性队列研究,连续纳入2006年1月至2017年12月在北京协和医院住院植入ICD用于一级预防的心脏病患者,患者在住院期间ICD植入前均完善Holter检查。根据Holter检查是否出现NSVT,将患者分为NSVT组及无NSVT组。门诊或电话随访至2018年8月,随访事件包括全因死亡、植入后ICD放电治疗及抗心动过速起搏(antitachycardia pacing,ATP)治疗情况。结果纳入60例符合入选和排除标准的患者,随访时间37 (14～61)个月,KaplanMeier生存曲线及Log-Rank检验提示,NSVT组与无NSVT组相比,全因死亡率无统计学差异(P=0. 108),NSVT组恰当治疗的风险高于无NSVT组(P=0. 033),NSVT和左心室射血分数与ICD恰当治疗独立相关(NSVT:HR=5. 099,95%CI:1. 399～18. 588,P=0. 014;左心室射血分数:HR=1. 077,95%CI:1. 013～1. 145,P=0. 018)。结论 ICD一级预防患者植入前出现NSVT提示接受ICD恰当治疗的风险增加。.
Objective The aim of this study was to explore the relationship between non-sustained ventricular tachycardia( NSVT) recorded by Holter before implantation and appropriate therapy in patients with implantable cardioverter defibrillator( ICD) for primary prevention of sudden cardiac death. Methods A singlecenter retrospective cohort study was conducted. Consecutive inpatients who received ICD for primary prevention and finished Holter examination from January 2006 to December 2017 in Peking Union Medical College Hospital were enrolled. According to the results of Holter,the patients were divided into the NSVT group and the nonNSVT group. Clinic or telephone follow-ups were conducted until August 2018; the follow-up events included all-cause death,shock therapy,and anti-tachycardia pacing( ATP). Results Sixty patients meeting the inclusive and exclusive criteria were enrolled in this study. Median follow-up of all patients was 37( 14-61)months. Kaplan-Meier curve and Log-Rank test showed that there was no significant difference in mortality between the NSVT and the non-NSVT group( P = 0. 108),while the NSVT group had a significantly higher rate of appropriate therapy( P = 0. 033). Multivariate competitive risk regression analysis indicated that NSVT and left ventricular ejection fraction were independently correlated with the ICD appropriate therapy( NSVT: HR =5. 099,95% CI: 1. 399-18. 588,P = 0. 014; left ventricular ejection fraction: HR = 1. 077,95% CI: 1. 013-1. 145,P = 0. 018). Conclusion NSVT in patients with ICD implantation for primary prevention suggests an increased risk of receiving appropriate therapy..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019-09-24 2019 |
|---|---|
| Erschienen: |
2019-09-24 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2019 |
|---|---|
| Enthalten in: |
Xie he yi xue za zhi - (2019), 05 vom: 24. Sept., Seite 494-498 Original Letters: Enthalten in 协和医学杂志 (DE-600)2993781-4 (DE-600)2993781-4 北京市 : [Verlag nicht ermittelbar] |
| Reihe: |
China Academic Journals (CAJ), E, 医药卫生科技 = Medicine & Public Health |
|---|
| Sprache: |
Chinesisch |
|---|
| Weiterer Titel: |
Relationship between Non-sustained Ventricular Tachycardia before Implantation and Appropriate Therapy in Patients with Implantable Cardioverter Defibrillator for Primary Prevention of Sudden Cardiac Death |
|---|
| Beteiligte Personen: |
王震 [VerfasserIn] |
|---|
| Links: |
oversea.cnki.net [lizenzpflichtig] |
|---|
| Anmerkungen: |
Author info:WANG Zhen;CHENG Zhong-wei;CHEN Tai-bo;GAO Peng;FANG Quan;Department of Cardiology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
CAJ639550177 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | CAJ639550177 | ||
| 003 | DE-627 | ||
| 005 | 20230120194848.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230103s2019 cc |||||o 00| ||chi c | ||
| 035 | |a (DE-627)CAJ639550177 | ||
| 035 | |a (SBB-XA)CAJ_XHYX201905013 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a chi | ||
| 044 | |c XB-CN | ||
| 084 | |a ASIEN |q DE-1a |2 fid | ||
| 084 | |a R541.7 |2 clc | ||
| 100 | 0 | |a 王震 |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 心源性猝死一级预防植入心律转复除颤器前非持续室性心动过速与植入后恰当治疗的关系 |b = Relationship between Non-sustained Ventricular Tachycardia before Implantation and Appropriate Therapy in Patients with Implantable Cardioverter Defibrillator for Primary Prevention of Sudden Cardiac Death |
| 246 | 3 | 1 | |a Relationship between Non-sustained Ventricular Tachycardia before Implantation and Appropriate Therapy in Patients with Implantable Cardioverter Defibrillator for Primary Prevention of Sudden Cardiac Death |
| 264 | 1 | |c 2019-09-24 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a China Academic Journals (CAJ) |a E |a 医药卫生科技 = Medicine & Public Health | |
| 500 | |a Author info:WANG Zhen;CHENG Zhong-wei;CHEN Tai-bo;GAO Peng;FANG Quan;Department of Cardiology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College | ||
| 520 | |a 目的探讨植入型心律转复除颤器(implantable cardioverter defibrillator,ICD)用于心源性猝死一级预防时,植入前发生非持续性室性心动过速(non-sustained ventricular tachycardia,NSVT)与植入后ICD恰当治疗的关系。方法本研究为单中心回顾性队列研究,连续纳入2006年1月至2017年12月在北京协和医院住院植入ICD用于一级预防的心脏病患者,患者在住院期间ICD植入前均完善Holter检查。根据Holter检查是否出现NSVT,将患者分为NSVT组及无NSVT组。门诊或电话随访至2018年8月,随访事件包括全因死亡、植入后ICD放电治疗及抗心动过速起搏(antitachycardia pacing,ATP)治疗情况。结果纳入60例符合入选和排除标准的患者,随访时间37 (14～61)个月,KaplanMeier生存曲线及Log-Rank检验提示,NSVT组与无NSVT组相比,全因死亡率无统计学差异(P=0. 108),NSVT组恰当治疗的风险高于无NSVT组(P=0. 033),NSVT和左心室射血分数与ICD恰当治疗独立相关(NSVT:HR=5. 099,95%CI:1. 399～18. 588,P=0. 014;左心室射血分数:HR=1. 077,95%CI:1. 013～1. 145,P=0. 018)。结论 ICD一级预防患者植入前出现NSVT提示接受ICD恰当治疗的风险增加。 | ||
| 520 | |a Objective The aim of this study was to explore the relationship between non-sustained ventricular tachycardia( NSVT) recorded by Holter before implantation and appropriate therapy in patients with implantable cardioverter defibrillator( ICD) for primary prevention of sudden cardiac death. Methods A singlecenter retrospective cohort study was conducted. Consecutive inpatients who received ICD for primary prevention and finished Holter examination from January 2006 to December 2017 in Peking Union Medical College Hospital were enrolled. According to the results of Holter,the patients were divided into the NSVT group and the nonNSVT group. Clinic or telephone follow-ups were conducted until August 2018; the follow-up events included all-cause death,shock therapy,and anti-tachycardia pacing( ATP). Results Sixty patients meeting the inclusive and exclusive criteria were enrolled in this study. Median follow-up of all patients was 37( 14-61)months. Kaplan-Meier curve and Log-Rank test showed that there was no significant difference in mortality between the NSVT and the non-NSVT group( P = 0. 108),while the NSVT group had a significantly higher rate of appropriate therapy( P = 0. 033). Multivariate competitive risk regression analysis indicated that NSVT and left ventricular ejection fraction were independently correlated with the ICD appropriate therapy( NSVT: HR =5. 099,95% CI: 1. 399-18. 588,P = 0. 014; left ventricular ejection fraction: HR = 1. 077,95% CI: 1. 013-1. 145,P = 0. 018). Conclusion NSVT in patients with ICD implantation for primary prevention suggests an increased risk of receiving appropriate therapy. | ||
| 610 | 2 | 4 | |a 中国医学科学院北京协和医学院北京协和医院心内科 |
| 650 | 4 | |a 心脏、血管（循环系）疾病 | |
| 650 | 4 | |a 内科学 | |
| 650 | 4 | |a 医药、卫生 | |
| 650 | 4 | |a Cardiovascular System Disease | |
| 650 | 4 | |a 医药卫生科技 | |
| 650 | 4 | |a Medicine & Public Health | |
| 650 | 4 | |a 植入型心律转复除颤器 | |
| 650 | 4 | |a 非持续性室性心动过速 | |
| 650 | 4 | |a 恰当治疗 | |
| 650 | 4 | |a 全因死亡 | |
| 650 | 4 | |a 左心室射血分数 | |
| 650 | 4 | |a implantable cardioverter defibrillator | |
| 650 | 4 | |a non-persistent ventricular tachycardia | |
| 650 | 4 | |a appropriate therapy | |
| 650 | 4 | |a all-cause death | |
| 650 | 4 | |a left ventricular ejection fraction | |
| 700 | 0 | |a 程中伟 |4 oth | |
| 700 | 0 | |a 陈太波 |4 oth | |
| 700 | 0 | |a 高鹏 |4 oth | |
| 700 | 0 | |a 方全 |4 oth | |
| 773 | 0 | 8 | |6 880-01 |i Enthalten in |t Xie he yi xue za zhi |d Bei jing shi : [Verlag nicht ermittelbar], 2010 |g (2019), 05 vom: 24. Sept., Seite 494-498 |h Online-Ressource |w (DE-627)CAJ34371700X |w (DE-600)2993781-4 |7 nnns |
| 773 | 1 | 8 | |g year:2019 |g number:05 |g day:24 |g month:09 |g pages:494-498 |
| 856 | 4 | 0 | |u http://erf.sbb.spk-berlin.de/han/caj/oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=XHYX201905013 |x Verlag |y CrossAsia Link |z Deutschlandweit zugänglich |
| 856 | 4 | 0 | |u https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=XHYX201905013 |x Verlag |z lizenzpflichtig |
| 880 | 0 | 8 | |6 773-01/Hans |i Enthalten in |t 协和医学杂志 |d 北京市 : [Verlag nicht ermittelbar] |h Online-Ressource |w (DE-627)CAJ34371700X |w (DE-600)2993781-4 |7 nnns |
| 912 | |a ZDB-1-CAJ | ||
| 912 | |a GBV_NL_CAJ | ||
| 912 | |a FID-ASIEN | ||
| 912 | |a SSG-OLC-OA3.1 | ||
| 912 | |a SSG-OLC-CAJ | ||
| 936 | u | w | |j 2019 |e 05 |b 24 |c 09 |h 494-498 |
| 951 | |a AR | ||
| 952 | |j 2019 |e 05 |b 24 |c 09 |h 494-498 | ||
| 980 | |2 11 |1 01 |x 0001 |b 659055031 |c 00 |f 5:FIDXASIA |d --%%-- |e --%%-- |j --%%-- |y k |z 03-01-23 | ||
| 981 | |2 11 |1 01 |x 0001 |r http://erf.sbb.spk-berlin.de/han/caj/oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=XHYX201905013 | ||